Genocea Biosciences Inc Beta
Quel est le Beta de Genocea Biosciences Inc?
Le Beta de Genocea Biosciences Inc est 0.00
Quelle est la définition de Beta?
BETA indique si une action est plus ou moins volatile que le marché dans son ensemble. Un bêta inférieur à 1 indique que l'action est moins volatile que le marché, tandis qu'un bêta supérieur à 1 indique que l'action est plus volatile. La volatilité est mesurée par la fluctuation du prix autour de la moyenne.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta des entreprises dans Health Care secteur sur NASDAQ par rapport à Genocea Biosciences Inc
Que fait Genocea Biosciences Inc?
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.
Entreprises avec beta similaire à Genocea Biosciences Inc
- Vision Marine Technologies a Beta de 0.00
- Ely Gold Royalties a Beta de 0.00
- Glacier Lake Resources a Beta de 0.00
- Magnum Mining and Exploration a Beta de 0.00
- Africa Opportunity Fund a Beta de 0.00
- Fulcrum Utility Services a Beta de 0.00
- Genocea Biosciences Inc a Beta de 0.00
- Gullewa a Beta de 0.00
- S.A.L. Steel a Beta de 0.00
- Andina Acquisition III a Beta de 0.00
- Andina Acquisition III a Beta de 0.00
- Brilliant Acquisition a Beta de 0.00
- Indokem a Beta de 0.00